Preprint · OA
via OpenAlex
A role for mammalian target of rapamycin (mTOR) pathway in non alcoholic steatohepatitis related-cirrhosis.
Márcia Saldanha Kubrusly, Maria Lúcia Corrêa‐Giannella, Marta Bellodi‐Privato, Sandra Valéria de Sá, Claudia Pinto Marques Souza de Oliveira, Iberê Cauduro Soares, Alda Wakamatsu, Venâncio Avancini Ferreira Alves, Daniel Giannella‐Neto, Telésforo Bacchella, Marcel Cerqueira César Machado, Luiz Augusto Carneiro D′Albuquerque
PubMed · 2010 · ▲ 28 citations
Abstract
UNLABELLED: Non-alcoholic fatty liver disease (NAFLD) encompasses the whole spectrum of steatosis, non-alcoholic steatohepatitis (NASH), and NASH-related cirrhosis (NASH/Cir). Although molecular advances have been made in this field, the pathogenesis of NAFLD is not completely understood. The gene expression profiling associated to NASH/Cir was assessed, in an attempt to better characterize the pathways involved in its etiopathogenesis. METHODS: In the first step, we used cDNA microarray to evaluate the gene expression profiles in normal liver (n=3) and NASH/Cir samples (n=3) by GeneSifter analysis to identify differentially expressed genes and biological pathways. Second, tissue microarray was used to determine immunohistochemical expression of phosphorylated mTOR(definition) and 4E-BP1 in 11 normal liver samples, 10 NASH/Cir samples and in 37 samples of cirrhosis of other etiologies to further explore the involvement of the mTOR pathway evidenced by the gene expression analysis. RESULTS: 138 and 106 genes were, respectively, up and down regulated in NASH/Cir in comparison to normal liver. Among the 9 pathways identified as significantly modulated in NASH/Cir, the participation of the mTOR pathway was confirmed, since expression of cytoplasmic and membrane phospho-mTOR were higher in NASH/Cir in comparison to cirrhosis of other etiologies and to normal liver. CONCLUSIONS: Recent findings have suggested a role for the cellular "nutrient sensor" mTOR in NAFLD and the present study corroborates the participation of this pathway in NASH/Cir. Phospho-mTOR evaluation might be of clinical utility as a potential marker for identification of NASH/Cir in cases mistakenly considered as cryptogenic cirrhosis owing to paucity of clinical data.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.14670/hh-25.1123
- Canonical
- link ↗
- Fetched
- 2026-09-24 MST
Cite this
APA
Kubrusly, M.S., Corrêa‐Giannella, M.L., Bellodi‐Privato, M., Sá, S.V.D., Oliveira, C.P.M.S.D., Soares, I.C., Wakamatsu, A., Alves, V.A.F., Giannella‐Neto, D., Bacchella, T., Machado, M.C.C., & D′Albuquerque, L.A.C. (2010). A role for mammalian target of rapamycin (mTOR) pathway in non alcoholic steatohepatitis related-cirrhosis. <em>PubMed</em>. https://doi.org/10.14670/hh-25.1123
Vancouver
Kubrusly MS, Corrêa‐Giannella ML, Bellodi‐Privato M, Sá SVD, Oliveira CPMSD, Soares IC, et al. A role for mammalian target of rapamycin (mTOR) pathway in non alcoholic steatohepatitis related-cirrhosis. PubMed. 2010. doi:10.14670/hh-25.1123.
BibTeX
@unpublished{mrcia2010Arolef,
title = {A role for mammalian target of rapamycin (mTOR) pathway in non alcoholic steatohepatitis related-cirrhosis.},
author = {Márcia Saldanha Kubrusly and Maria Lúcia Corrêa‐Giannella and Marta Bellodi‐Privato and Sandra Valéria de Sá and Claudia Pinto Marques Souza de Oliveira and Iberê Cauduro Soares and Alda Wakamatsu and Venâncio Avancini Ferreira Alves and Daniel Giannella‐Neto and Telésforo Bacchella and Marcel Cerqueira César Machado and Luiz Augusto Carneiro D′Albuquerque},
journal = {PubMed},
year = {2010},
doi = {10.14670/hh-25.1123},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2014
Open access · CC-BY
ins-7 Gene Expression Is Partially Regulated by the DAF-16/IIS Signaling Pathway in Caenorhabditis elegans under Celecoxib Intervention
Acta Marisiensis. Seria Medica 2023
Open access · CC-BY
Intermittent fasting for the management of NAFLD: Is there enough evidence?
The Journals of Gerontology Series A 2014
Open access · OA
Rapamycin and Dietary Restriction Induce Metabolically Distinctive Changes in Mouse Liver
Shanghai Zhongshan Hospital 2018
Open access · US-GOV
The Effect of Calcium β-hydroxy-β-methylbutyrate Supplementation in Sarcopenia in Liver Cirrhosis:A Randomized Double-blind Controlled Trial
Therapeutic Advances in Medical Oncology 2024
Open access · CC-BY
Inhibition of the PI3K/AKT/mTOR pathway in pancreatic cancer: is it a worthwhile endeavor?
Frontiers in Pharmacology 2024
Open access · CC-BY